APLN shares a close relationship with TNF α expression in adipose tissue, which has led to its consideration as a potential bridge mediator between inflammation and insulin resistance in obesity (7, 50), though body-mass is likely not a major determinant of its circulating forms (51). The gene discussed is APLN; the disease is obesity due to melanocortin 4 receptor deficiency.